![[ICO]](/icons/blank.gif){kind=icon}
![[PARENTDIR]](/icons/back.gif){kind=icon}
![[ ]](/icons/layout.gif){kind=icon}
| Name | Last modified | Size | Description |
|---|---|---|---|---|
| Parent Directory | - | ||
| Appendix_(incl.protocol_phase_1_2)_Lancet_publication_Nov_2020-mmc2.pdf | 2020-11-26 16:46 | 5.3M | |
| Appendix_(incl.protocol_phase_2_3)_Lancet_publication_Nov_2020-mmc1.pdf | 2020-11-26 17:01 | 6.2M | |
| C4591001_Clinical_Protocol-Pfizer_BioNTech-Sep-2020.pdf | 2020-11-26 16:41 | 1.2M | |
| C4591001_Clinical_Protocol-Pfizer_BioNTech_(Updated)-Nov-2020.pdf | 2020-11-26 17:16 | 1.3M | |
| D8110C00001_CSP-v2_AstraZeneca_protocol.pdf | 2020-11-26 16:44 | 628K | |
| covid-19-phase-3-study-clinical-protocol_Janssen_Vaccines_&_Prevention_B.V_Protocol_VAC31518COV3001;_Phase 3.pdf | 2020-11-26 17:03 | 2.0M | |
| mRNA-1273-P301-Protocol_ModernaTX_Inc_Aug_2020.pdf | 2020-11-26 17:05 | 2.0M | |